Protalix Biotherapeutics, Inc. (PLX)

1.75 +0.01 (+0.57%) USD  |  NYAM  |  Dec 09, 10:27
More

Protalix Biotherapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
GlucoTrack, Inc. Upgrade
PAVmed, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade